Market Cap 1.27B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,589,000
Avg Vol 5,545,602
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 7%
Beta 1.02
Analysts Strong Sell
Price Target $10.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
superdupersocks
superdupersocks May. 20 at 2:10 AM
$ABCL interesting read. https://open.substack.com/pub/dhcfund/p/abcellera-biologics
1 · Reply
Ed_Ng
Ed_Ng May. 20 at 12:27 AM
$ABCL anything they promised during the past 6 years is scam.
0 · Reply
VoxChameleon
VoxChameleon May. 19 at 11:41 PM
$ABCL idiotic to short a company like this with Hantavirus, Ebola etc going off right now. Some shorts just beg to get destroyed.
1 · Reply
VoxChameleon
VoxChameleon May. 19 at 11:39 PM
$ABCL Ebola antibody news coming. Shorts gonna be mad mad.
0 · Reply
tradersunion353
tradersunion353 May. 19 at 10:08 PM
$ABCL looks like scam want drop badly before and after phase 2 Data overhyped junk
1 · Reply
DeMampCamp
DeMampCamp May. 19 at 3:22 PM
$ABCL The one's flipping the stock love this, those that have your long position, hate it! With that said, it certainly does seem as if this is right around the bottom, I still expect a 50ma touch, but that's only .10 cents away, but even that seems to be quite challenging.
0 · Reply
tkstockpicker
tkstockpicker May. 19 at 3:19 PM
$ABCL Bought back this lot
0 · Reply
tradersunion353
tradersunion353 May. 19 at 3:11 PM
$ABCL Scam is getting destroyed. At his rate there willl be reverse split as soon as phase 2 data is out,,,, drop to 1 dollar or lower then go with Reverse split Classic biotech scam
0 · Reply
tradersunion353
tradersunion353 May. 19 at 2:53 PM
$ABCL I am sure Demamp clown must be coming up those lust stories to defend his losing position in this scam.. what a clown aahh
0 · Reply
tradersunion353
tradersunion353 May. 19 at 2:51 PM
$ABCL Paper traders and who are married to this POS how your adding and loading working for last 5 years? 🤣
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 7 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 8 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 8 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 8 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 8 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 14 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 20 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 20 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 5 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 8 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


superdupersocks
superdupersocks May. 20 at 2:10 AM
$ABCL interesting read. https://open.substack.com/pub/dhcfund/p/abcellera-biologics
1 · Reply
Ed_Ng
Ed_Ng May. 20 at 12:27 AM
$ABCL anything they promised during the past 6 years is scam.
0 · Reply
VoxChameleon
VoxChameleon May. 19 at 11:41 PM
$ABCL idiotic to short a company like this with Hantavirus, Ebola etc going off right now. Some shorts just beg to get destroyed.
1 · Reply
VoxChameleon
VoxChameleon May. 19 at 11:39 PM
$ABCL Ebola antibody news coming. Shorts gonna be mad mad.
0 · Reply
tradersunion353
tradersunion353 May. 19 at 10:08 PM
$ABCL looks like scam want drop badly before and after phase 2 Data overhyped junk
1 · Reply
DeMampCamp
DeMampCamp May. 19 at 3:22 PM
$ABCL The one's flipping the stock love this, those that have your long position, hate it! With that said, it certainly does seem as if this is right around the bottom, I still expect a 50ma touch, but that's only .10 cents away, but even that seems to be quite challenging.
0 · Reply
tkstockpicker
tkstockpicker May. 19 at 3:19 PM
$ABCL Bought back this lot
0 · Reply
tradersunion353
tradersunion353 May. 19 at 3:11 PM
$ABCL Scam is getting destroyed. At his rate there willl be reverse split as soon as phase 2 data is out,,,, drop to 1 dollar or lower then go with Reverse split Classic biotech scam
0 · Reply
tradersunion353
tradersunion353 May. 19 at 2:53 PM
$ABCL I am sure Demamp clown must be coming up those lust stories to defend his losing position in this scam.. what a clown aahh
0 · Reply
tradersunion353
tradersunion353 May. 19 at 2:51 PM
$ABCL Paper traders and who are married to this POS how your adding and loading working for last 5 years? 🤣
0 · Reply
Rastafari
Rastafari May. 19 at 2:03 PM
$ABCL Come September time frame, many will be saying I wish I had loaded up! While, no one wants to see the price of these level, when you are given lemons, make lemonade!
2 · Reply
Ed_Ng
Ed_Ng May. 19 at 1:35 PM
$ABCL scam is still a scam. My short is doing very well
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 May. 19 at 1:26 PM
$ABCL buying opportunities 🙌
0 · Reply
tradersunion353
tradersunion353 May. 19 at 12:40 PM
$ABCL what are these clowns cheerleading and pumping when scam crashed 30% on phase 1 data?
0 · Reply
tranq19
tranq19 May. 19 at 9:03 AM
$ABCL wonder if we might see another Form 4 related to that 1.2M share buy around noon yesterday
0 · Reply
tranq19
tranq19 May. 19 at 8:42 AM
$ABCL John Montalbano, Director and former CEO of RBC Global Asset Management thought it was a good idea to pick up 20k shares at 4.77, 10% or so increase to position.
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:09 PM
$ABCL Dont fall for these paid pumpers.. especially clown Demamp Stock is bearish for 5 years even after phase 1 data stock did not perform.. What a junk POS.. looks like a scam to me
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:07 PM
$ABCL Overhyped underperforming Junk dropped from 5.60s to 4 dollars after phase 1 data Clowns are celebrating for what?
0 · Reply
Captain_Greed
Captain_Greed May. 18 at 10:56 PM
$EBS TRUMP ON EBOLA: I AM CONCERNED $NVAX $MRNA $ABCL
1 · Reply
8008track
8008track May. 18 at 10:26 PM
$ABCL generational company in the making
0 · Reply
TradeWinner
TradeWinner May. 18 at 9:27 PM
$ABCL ho hum again. Hold the course.
0 · Reply
freedomtrader6
freedomtrader6 May. 18 at 8:51 PM
Today’s portfolio action was intense. Inflation-hedged bond ETF ripping $AGRO, $BB, $ABCL, $LPTH all green—feels good watching this But here’s the reality: I hedged SPX two weeks ago. The recent parabolic move ate into a lot of profits. Portfolio at ATH, but not breaking through the all-time high—like standing at the summit but unable to climb higher. As my friend always says: being early can sometimes feel the same as being wrong. Felt that firsthand today. The market is testing patience—and showing who can really hold their ground.
0 · Reply